My Member
Message Center
trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
-
China seeks to increase supply of traditional Chinese medicine services
China has been dedicated to increasing the supply of traditional Chinese medicine (TCM) services. By Aug. 2, 2020, the number of registered traditional TCM clinics has reached 18,785, a huge rise from 195 in 2017 and 8,376 in 2018.
2020-08-27 -
TCM veteran still healing during pandemic
Although in his 70s, Liu Huawei, a well-known practitioner of traditional Chinese medicine in Northwest China's Shaanxi province, still contributes to the prevention and control of COVID-19 in his own way.
2020-08-26 -
WHO aiming for 2b doses of vaccine by end of 2021
Global initiative seeks to ensure equal access when supplies are available
2020-08-26 -
More research on virus sought
Experts call for increased international unity to learn about long-term maladies
2020-08-25 -
Chinese inactivated COVID-19 vaccine starts phase-3 clinical trials in Argentina
BEIJING, Aug. 22 (Xinhua) -- An inactivated COVID-19 vaccine developed by China has started phase-3 clinical trials in Argentina, according to its developer China National Biotec Group (CNBG), which is affiliated to Sinopharm.
2020-08-24Innovation -
Cytokine storms may prevent the development of long-term immunity to SARS-CoV-2
Shiv Pillai, MD, PhD recently published a paper in Cell showing that that high levels of some cytokines seen in COVID-19 patients may prevent the development of long-term immunity to SARS-CoV-2, the virus that causes COVID-19.
2020-08-21 -
China approves patent to COVID-19 vaccine
China has granted its first COVID-19 vaccine patent to the adenovirus vector vaccine developed by Chen Wei of the Academy of Military Medical Sciences and Chinese biotech company CanSino Biologics.
2020-08-20Innovation -
China-developed COVID-19 vaccine ready to go onto market this Dec
Inactivated COVID-19 vaccine candidates developed by a Chinese pharmaceutical company are likely to be on the market by the end of December, at a price of less than 1,000 yuan ($144) for two doses.
2020-08-19Innovation -
High-Quality Chinese Medical Supplier-Guangdong Dicallo Co.,Ltd
Dicallo tech, focusing on disinfection products, protective products, medical products, escort for your health, high level dust-free workshops, advanced automatic equipments, ensure quality reach international standard.
2020-08-19 -
Chinese COVID-19 vaccine shows promising trial results: study
BEIJING - An inactivated COVID-19 vaccine candidate developed by China is safe and generates an immune response, according to data from clinical trials published in The Journal of the American Medical Association this week.
2020-08-17